- Global Pharma News & Resources

Press Releases - 2019-05-01

Date Title Company
01-May-2019 Nektar to Announce Financial Results for the First Quarter 2019 on Wednesday, May 8, 2019, After Close of U.S.-Based Financial Markets Nektar Therapeutics
01-May-2019 NuVasive Announces First Quarter 2019 Financial Results NuVasive, Inc.
01-May-2019 Sangamo Therapeutics Announces First Quarter 2019 Conference Call And Webcast Sangamo Therapeutics, Inc.
01-May-2019 Sandoz enters agreement for proposed trastuzumab biosimilar, currently in phase III development, to treat selected HER2-positive cancer tumors Sandoz
01-May-2019 Learning about Rare Genetic Disorders on Undiagnosed Children’s Day emotive
01-May-2019 emotive appoints a Mental Health First Aider emotive
01-May-2019 PMI® at 52.8%; April Manufacturing ISM® Report On Business® Institute for Supply Management
01-May-2019 Lyophilization Explained in its Simplest Terms SMi Group Ltd
01-May-2019 Boston Scientific to Participate in Bank of America Merrill Lynch Healthcare Conference 2019 Boston Scientific
01-May-2019 Oxford Finance Closes $60 Million Credit Facility with Oncology Innovator RefleXion Medical Oxford Finance LLC
01-May-2019 Smith & Nephew Adopts One-platform Approach with Medidata to Support Expansion of Study Portfolio Medidata
01-May-2019 Manufacturing growth sees surging demand at CPhI South East Asia CPhI
01-May-2019 LAL-D Treatment Market Size Worth $954 Million by 2025 : Grand View Research, Inc. Grand View Research, Inc.
01-May-2019 United Therapeutics Corporation Reports First Quarter 2019 Financial Results United Therapeutics Corporation
01-May-2019 Visiongain Report Researches Growth Opportunities Within the $14bn Biosimilars and Follow-On Biologics Drugs Market Visiongain